4.7 Article

A mechanistic basis for amplification differences between samples and between genome regions

期刊

BMC GENOMICS
卷 13, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/1471-2164-13-455

关键词

DNA amplification; DNA denaturation; C plus G; Illumina infinium

资金

  1. Action Medical Research [SP4139, SP4483]
  2. European Union [FP7/2007-2013]
  3. READNA [HEALTH-F4-2008-201418]

向作者/读者索取更多资源

Background: For many analytical methods the efficiency of DNA amplification varies across the genome and between samples. The most affected genome regions tend to correlate with high C + G content, however this relationship is complex and does not explain why the direction and magnitude of effects varies considerably between samples. Results: Here, we provide evidence that sequence elements that are particularly high in C + G content can remain annealed even when aggressive melting conditions are applied. In turn, this behavior creates broader 'Thermodynamically Ultra-Fastened' (TUF) regions characterized by incomplete denaturation of the two DNA strands, so reducing amplification efficiency throughout these domains. Conclusions: This model provides a mechanistic explanation for why some genome regions are particularly difficult to amplify and assay in many procedures, and importantly it also explains inter-sample variability of this behavior. That is, DNA samples of varying quality will carry more or fewer nicks and breaks, and hence their intact TUF regions will have different lengths and so be differentially affected by this amplification suppression mechanism with 'higher' quality DNAs being the most vulnerable. A major practical consequence of this is that inter-region and inter-sample variability can be largely overcome by employing routine fragmentation methods (e. g. sonication or restriction enzyme digestion) prior to sample amplification.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Psychology, Clinical

Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; the EU-GEI study

Victoria Rodriguez, Luis Alameda, Diego Quattrone, Giada Tripoli, Charlotte Gayer-Anderson, Edoardo Spinazzola, Giulia Trotta, Hannah E. Jongsma, Simona Stilo, Caterina La Cascia, Laura Ferraro, Daniele La Barbera, Antonio Lasalvia, Sarah Tosato, Ilaria Tarricone, Elena Bonora, Stephane Jamain, Jean-Paul Selten, Eva Velthorst, Lieuwe de Haan, Pierre-Michel Llorca, Manuel Arrojo, Julio Bobes, Miguel Bernardo, Celso Arango, James Kirkbride, Peter B. Jones, Bart P. Rutten, Alexander Richards, Pak C. Sham, Michael O'Donovan, Jim Van Os, Craig Morgan, Marta Di Forti, Robin M. Murray, Evangelos Vassos

Summary: This study suggests that combining polygenic risk scores (PRS) for severe psychiatric disorders with prediction models for psychosis phenotypes can improve discrimination ability and enhance our understanding of these phenotypes. PRS may have potential usefulness in specific populations such as those at high risk or in the early stages of psychosis.

PSYCHOLOGICAL MEDICINE (2023)

Article Medicine, General & Internal

Self-Reported Pain and Emotional Reactivity in Bipolar Disorder: A Prospective FACE-BD Study

Nathan Risch, Jonathan Dubois, Katia M'bailara, Irena Cussac, Bruno Etain, Raoul Belzeaux, Caroline Dubertret, Emmanuel Haffen, Raymund Schwan, Ludovic Samalin, Paul Roux, Mircea Polosan, Marion Leboyer, Philippe Courtet, Emilie Olie

Summary: In patients with bipolar disorder, pain prevalence is close to 30%. This study found that pain was associated with depressive symptomatology, emotional reactivity, and personality traits. Furthermore, pain predicted depression and lower global life functioning in the long-term.

JOURNAL OF CLINICAL MEDICINE (2022)

Review Clinical Neurology

Strategies and foundations for scientific discovery in longitudinal studies of bipolar disorder

Melvin G. McInnis, Ole A. Andreassen, Ana C. Andreazza, Uri Alon, Michael Berk, Teri Brister, Katherine E. Burdick, Donghong Cui, Mark Frye, Marion Leboyer, Philip B. Mitchell, Kathleen Merikangas, Andrew A. Nierenberg, John Nurnberger, Daniel Pham, Eduard Vieta, Lakshmi N. Yatham, Allan H. Young

Summary: Bipolar disorder is a complex condition with onset in late adolescence, complicated by comorbid medical and psychiatric disorders. The etiology and reliable biological markers remain unknown, suggesting the need for large-scale global longitudinal studies to determine causes and improve treatment.

BIPOLAR DISORDERS (2022)

Article Psychiatry

Telomere length and mitochondrial DNA copy number in bipolar disorder: A sibling study

Luana Spano, Bruno Etain, Jean-Louis Laplanche, Marion Leboyer, Sebastien Gard, Frank Bellivier, Cynthia Marie-Claire

Summary: This study finds consistency in cellular aging biomarkers between individuals with bipolar disorder and their siblings, suggesting shared environmental or genetic factors.

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2023)

Editorial Material Biochemical Research Methods

Ten simple rules for a successful international consortium in big data omics

Miranda D. Stobbe, Abel Gonzalez-Perez, Nuria Lopez-Bigas, Glynne Gut

PLOS COMPUTATIONAL BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Tackling the translational challenges of multi-omics research in the realm of European personalised medicine: A workshop report

Emanuela Oldoni, Gary Saunders, Florence Bietrix, Maria Laura Garcia Bermejo, Anna Niehues, Peter A. C. 't Hoen, Jessica Nordlund, Marian Hajduch, Andreas Scherer, Katja Kivinen, Esa Pitkanen, Tomi Pekka Makela, Ivo Gut, Serena Scollen, Lukasz Kozera, Manel Esteller, Leming Shi, Anton Ussi, Antonio L. Andreu, Alain J. van Gool

Summary: Personalised medicine (PM) offers a great opportunity to enhance individualized healthcare. Advances in -omics technologies have enabled the study of complex human diseases, supporting the development of PM. This article summarizes the outcomes of a workshop that aimed to outline common promises and challenges in multi-omics research, assess the potential of new technologies like artificial intelligence, and foster collaboration between key initiatives.

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

Article Archaeology

Enhancing mummy ?palaeobiographies? through the use of multidisciplinary techniques and approaches

K. N. White, D. Chiasserini, R. Loynes, A. R. David, B. E. van Dongen, K. Drosou, R. Forshaw, S. Fraser, P. Causey-Freeman, J. Metcalfe, E. Murphy, M. Regan, P. J. Reimer, D. G. Tosh, A. Whetton, A. J. Freemont

Summary: Scientific examination of mummies provides insights into human ancestry, diet, disease, cultures, and societies. However, invasive methods have raised concerns. A minimally invasive approach using imaging techniques and biopsy sampling allows for the collection of valuable data without significant disturbance to the mummy. This study on Takabuti demonstrates the potential of such methods.

JOURNAL OF ARCHAEOLOGICAL SCIENCE-REPORTS (2023)

Article Clinical Neurology

Use of a gene expression signature to identify trimetazidine for repurposing to treat bipolar depression

Chiara C. Bortolasci, Srisaiyini Kidnapillai, Briana Spolding, Trang T. T. Truong, Timothy Connor, Courtney Swinton, Bruna Panizzutti, Zoe S. J. Liu, Andrew Sanigorski, Olivia M. Dean, Tamsyn Crowley, Mark Richardson, Kiymet Bozaoglu, Katerina Vlahos, Stephanie Cowdery, Brad Watmuff, Stephan F. Steyn, De Wet Wolmarans, Barend J. Engelbrecht, Christina Perry, Katherine Drummond, Terence Pang, Stephane Jamain, Laura Gray, Sean L. McGee, Brian H. Harvey, Jee Hyun Kim, Marion Leboyer, Michael Berk, Ken Walder

Summary: The aim of this study was to identify a drug for repurposing in the treatment of bipolar depression. A gene expression signature was generated using human neuronal-like cells to represent the effects of drugs used to treat bipolar disorder. Trimetazidine was identified as a potential candidate for repurposing based on its similar transcriptional effects and its ability to increase ATP production.

BIPOLAR DISORDERS (2023)

Article Psychiatry

The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case-control study

Lucia Sideli, Monica Aas, Diego Quattrone, Daniele La Barbera, Caterina La Cascia, Laura Ferraro, Luis Alameda, Eva Velthorst, Giulia Trotta, Giada Tripoli, Adriano Schimmenti, Andrea Fontana, Charlotte Gayer-Anderson, Simona Stilo, Fabio Seminerio, Crocettarachele Sartorio, Giovanna Marrazzo, Antonio Lasalvia, Sarah Tosato, Ilaria Tarricone, Domenico Berardi, Giuseppe D'Andrea, Celso Arango, Manuel Arrojo, Miguel Bernardo, Julio Bobes, Julio Sanjuan, Jose Luis Santos, Paulo Rossi Menezes, Cristina Marta Del-Ben, Hannah E. Jongsma, Peter B. Jones, James B. Kirkbride, Pierre-Michel Llorca, Andrea Tortell, Baptiste Pignon, Lieuwe de Haan, Jean-Paul Selten, Jim Van Os, Bart P. Rutten, Richard Bentall, Marta Di Fort, Robin M. Murray, Craig Morgan, Helen L. Fisher

Summary: This study aimed to investigate whether the relationship between childhood maltreatment and cognition in patients with psychosis and community controls was influenced by genetic factors related to psychosis. The study included first-episode psychosis patients (N=755) and unaffected controls (N=1219) from the EU-GEI study, who were assessed for childhood maltreatment, intelligence quotient (IQ), family history of psychosis (FH), and polygenic risk score for schizophrenia (SZ-PRS). The results showed that controlling for FH and SZ-PRS did not weaken the association between childhood maltreatment and IQ in either cases or controls, suggesting that genetic liability factors do not explain the lower levels of cognition in adults who experienced childhood maltreatment.

SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2023)

Article Genetics & Heredity

Understanding the relationship between cerebellar structure and social abilities

Yannis Elandaloussi, Dorothea L. Floris, Pierrick Coupe, Edouard Duchesnay, Angeline Mihailov, Antoine Grigis, Indrit Begue, Julie Victor, Vincent Frouin, Marion Leboyer, Josselin Houenou, Charles Laidi

Summary: This study analyzed structural MRI data from a large pediatric and transdiagnostic sample and found a significant association between cerebellar volume and social difficulties. The results reveal a complex relationship between cerebellar structure, social performance, and IQ.

MOLECULAR AUTISM (2023)

Article Biochemistry & Molecular Biology

The risk of hospitalization for psychotic disorders following hospitalization for COVID-19: a French nationwide longitudinal study

Baptiste Pignon, Valentina Decio, Philippe Pirard, Olivier Bouaziz, Emmanuelle Corruble, Pierre A. Geoffroy, Viviane Kovess-Masfety, Marion Leboyer, Cedric Lemogne, Jonathan Messika, Vittorio Perduca, Franck Schurhoff, Nolwenn Regnault, Sarah Tebeka

Summary: COVID-19 may not increase the risk of hospitalization for psychotic disorders, as patients initially hospitalized for COVID-19 had a lower rate of subsequent hospitalization for psychotic disorders compared to those initially hospitalized for other reasons. This finding contradicts the hypothesis that there is an increased risk of psychotic disorders after a severe COVID-19 infection. Importantly, a history of psychotic disorder was found to be a major determinant of hospitalization for psychotic disorders.

MOLECULAR PSYCHIATRY (2023)

Correction Genetics & Heredity

Understanding the relationship between cerebellar structure and social abilities (vol 14,18, 2023)

Yannis Elandaloussi, Dorothea L. L. Floris, Pierrick Coupe, Edouard Duchesnay, Angeline Mihailov, Antoine Grigis, Indrit Begue, Julie Victor, Vincent Frouin, Marion Leboyer, Josselin Houenou, Charles Laidi

MOLECULAR AUTISM (2023)

Article Neurosciences

Evolution of Cognitive Impairments in Treatment-Resistant Depression: Results from the Longitudinal French Centers of Expertise for Treatment-Resistant Depression (FACE-DR) Cohort

Alexis Vancappel, Yecodji Dansou, Ophelia Godin, Emmanuel Haffen, Antoine Yrondi, Florian Stephan, Raphaelle Marie Richieri, Fanny Moliere, Jerome Holtzmann, Mathilde Horn, Etienne Allauze, Jean Baptiste Genty, Alex Bouvard, Jean-Michel Dorey, Vincent Hennion, Vincent Camus, Guillaume Fond, Barbara Peran, Michel Walter, Loic Anguill, Charlotte Scotto D'apolina, Estelle Vila, Benjamin Fredembach, Jean Petrucci, Romain Rey, Anne Sophie Nguon, Bruno Etain, Mathilde Carminati, Philippe Courtet, Guillaume Vaiva, Pierre Michel Llorca, Marion Leboyer, Bruno Aouizerate, Djamila Bennabi, Wissam El Hage

Summary: This study examines the relationship between cognitive impairments and treatment response in patients with treatment-resistant depression. The findings suggest that cognitive scores improve after therapeutic response, with greater improvement observed in patients with better treatment response. Therefore, cognitive remediation should be provided after therapeutic response to enhance patients' daily functioning.

BRAIN SCIENCES (2023)

Article Genetics & Heredity

Risperidone response in patients with schizophrenia drives DNA methylation changes in immune and neuronal systems

Ana Lokmer, Charanraj Goud Alladi, Rejane Troudet, Delphine Bacq-Daian, Anne Boland-Auge, Violaine Latapie, Jean-Francois Deleuze, Ravi Philip RajKumar, Deepak Gopal Shewade, Frank Belivier, Cynthia Marie-Claire, Stephane Jamain

Summary: The use of antipsychotic medication to treat schizophrenia is not always effective for all patients. Researchers have analyzed the blood DNA of patients and identified specific marks that could serve as biomarkers of antipsychotic response. Although specific predictive marks were not identified, valuable targets for future research have been identified.

EPIGENOMICS (2023)

Article Psychiatry

Genetic and psychosocial stressors have independent effects on the level of subclinical psychosis: findings from the multinational EU-GEI study

B. Pignon, H. Peyre, A. Ayrolles, J. B. Kirkbride, S. Jamain, A. Ferchiou, J. R. Richard, G. Baudin, S. Tosato, H. Jongsma, L. de Haan, I Tarricone, M. Bernardo, E. Velthorst, M. Braca, C. Arango, M. Arrojo, J. Bobes, C. M. Del-Ben, M. Di Forti, C. Gayer-Anderson, P. B. Jones, C. La Cascia, A. Lasalvia, P. R. Menezes, D. Quattrone, J. Sanjuan, J. P. Selten, A. Tortelli, P. M. Llorca, J. van Os, B. P. F. Rutten, R. M. Murray, C. Morgan, M. Leboyer, A. Szoke, F. Schurhoff

Summary: This study on subjects without psychotic disorders suggests that the positive dimension of subclinical psychosis may be particularly influenced by both genetic and environmental factors independently, and interactions between genetic and individual environmental factors were not identified in this sample.

EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES (2022)

暂无数据